NCT03165422View on ClinicalTrials.gov

A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 29, 2018

Study Completion Date

December 29, 2018

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

1050001

Local Institution, Minato-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03165422 - A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan | Biotech Hunter | Biotech Hunter